NCT07217145 2026-04-07
PREVENT HPV -Related Cancers Trial
University of Utah
Phase 3 Active not recruiting
Clinical Trials
5 trialsNCT03903562 2026-04-06
V503-024
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04255849 2026-01-23
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
Weill Medical College of Cornell University
Phase 3 Active not recruiting
NCT06632912 2026-01-23
Phase IIIb Clinical Trial of Quadrivalent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) for Age/Immunization Schedule Bridging
National Vaccine and Serum Institute, China
Phase 3 Active not recruiting